Submitted by Anonymous (not verified) on 19 June 2024 - 15:08
Human medicines European public assessment report (EPAR): Eviplera, emtricitabine,rilpivirine,tenofovir disoproxil, Date of authorisation: 27/11/2011, Revision: 26, Status: Authorised
Source: